About Synerlab
Synerlab is a company based in Erstein (France) founded in 2000 was acquired by Blue Wolf Capital Partners in October 2024. Synerlab has completed 2 acquisitions, including Alcal Farma and Lyofal. Synerlab offers products and services including Lyophilisation Services, Sterile Multidose Services, Formulation Development, Packaging Services, and Regulatory Affairs. Synerlab operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Erstein, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$603.85 K (USD), Grant
Jan 15, 2021
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Alcal Farma
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synerlab
Synerlab offers a comprehensive portfolio of products and services, including Lyophilisation Services, Sterile Multidose Services, Formulation Development, Packaging Services, and Regulatory Affairs.
Freeze-drying services for pharmaceutical products and stability.
Expert manufacturing of sterile multidose formulations.
Analytical and process development for new drug formulations.
Tailored packaging solutions for various dosage forms.
Support for navigating EU pharmaceutical regulations.
Funding Insights of Synerlab
Investors in Synerlab
Synerlab has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Ministry of Economy, Finance and Industrial and Digital Sovereignty, Ardian and Naxicap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm specializing in markets and partnerships.
|
Locked | Locked | Locked | |
|
Investments in small and medium-sized businesses are managed by Naxicap.
|
Locked | Locked | Locked | |
|
Private equity investments in Europe are managed by the firm.
|
Locked | Locked | Locked |
Investor details for Synerlab
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synerlab
Synerlab has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Alcal Farma and Lyofal.
Investment portfolio details for Synerlab
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Online offering natural products
|
Locked | Locked | 2022 | Locked | |
|
CDMO for OTC products and food supplements.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for Synerlab
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Synerlab
Detailed financials for Synerlab
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synerlab Comparisons
Peer comparison for Synerlab
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synerlab
Synerlab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Synerlab
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synerlab
Complete news archive for Synerlab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synerlab
Synerlab was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Synerlab is headquartered in Erstein, France. It is registered at Erstein, Bas-rhin, France.
Synerlab was founded in 2000 in Erstein, France, as a contract development and manufacturing organization. Operations focus on the pharmaceutical, dietetic, veterinary, and dietary supplements sectors. Solid oral dosage forms are developed, manufacturing processes are handled, and custom packaging is offered to meet market needs. The company supports various clients through these specialized services in a regulated environment.
Synerlab's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Synerlab offers Lyophilisation Services, Sterile Multidose Services, Formulation Development, Packaging Services, and Regulatory Affairs.
Synerlab has made 2 acquisitions, including Alcal Farma, and Lyofal.
Synerlab has 5 investors. Key investors include Ministry of Economy, Finance and Industrial and Digital Sovereignty, Ardian, Naxicap, Blue Wolf Capital Partners, and 21 Invest.